All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, maker of Oxycontin, over the company's improper marketing of opioids.

According to several attorneys general, Monday's agreements do not include Oklahoma, which in 2019 reached a $270 million settlement with Purdue Pharma and the Sacklers to resolve opioid-related ...

Purdue Pharma, Sacklers reach new $7.4 billion opioid settlement. All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma ...

Updated June 27, 2025 at 3:28 PM EDT All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, maker of Oxycontin, over the ...

Under the outlines of the deal, members of the Sackler family who currently own Purdue Pharma are expected to contribute roughly $6.5 billion. According to the company, a major change from past ...